Work

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

Year: 2002

Type: article

Source: PubMed

Authors: Nadia Harbeck, Ronald E Kates, Maxime P Look, Marion E Meijer-Van Gelder, Jan G M Klijn, Achim Krüger, Marion Kiechle, Fritz Jänicke, Manfred Schmitt, John A Foekens

Institution: Technical University of Munich

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2105488671

FWCI: 5.907

Cites: 17

Cited by: 191

Related to: 10